Dow Up 1.63% Nasdaq Up 0.97%

Supernus Pharmaceuticals, Inc. (SUPN)

-NasdaqGM
7.88 Down 0.51(6.08%) Oct 17, 4:00PM EDT
Prev Close:8.39
Open:8.48
Bid:7.80 x 1000
Ask:8.49 x 1900
1y Target Est:12.08
Beta:1.56
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:7.85 - 8.48
52wk Range:5.84 - 11.47
Volume:280,573
Avg Vol (3m):429,163
Market Cap:338.22M
P/E (ttm):N/A
EPS (ttm):-1.59
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SUPN

Comparison

Symbol% ChgMkt Cap
SUPNDown 6.08%338.22M
JNJUp 1.98%278.36B

Key Statistics

Forward P/E (1 yr):24.62
P/S (ttm):7.15
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.11
Quarterly EPS Est (Sep-14) :0.36
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback